Heart Failure with Preserved Ejection Fraction Challenges
Heart failure with preserved ejection fraction (HFpEF) poses diagnostic and therapeutic challenges due to heterogeneity in pathophysiology.
Key Highlights:
- Diagnosis: Echocardiography and biomarkers aid in differentiating HFpEF from other cardiac conditions.
- Comorbidities: Hypertension, diabetes, obesity, and atrial fibrillation complicate management.
- Symptom management: Diuretics relieve congestion; exercise and lifestyle modification improve functional status.
- Novel therapies: Clinical trials explore SGLT2 inhibitors, mineralocorticoid receptor antagonists, and personalized medicine.
- Prognosis: Early identification and multidisciplinary management enhance quality of life and reduce hospitalizations.
Addressing HFpEF requires individualized care focusing on underlying causes and symptomatic improvement.
Related Conference of Heart Failure with Preserved Ejection Fraction Challenges
August 27-28, 2026
17th International Conference on Exhibition on Lasers, Optics & Photonics
Zurich, Switzerland
August 27-28, 2026
11th International Conference on Quantum Physics and Mechanics
Zurich, Switzerland
October 12-13, 2026
9th International Conference on Astronomy, Astrophysics and Space Science
Paris, France
October 26-27, 2026
6th International Conference on Applied Physics and Materials Science
Amsterdam, Netherlands

